Peoples Bancorp (PEBO) Q3 2026 Earnings Call Transcript

Peoples Bancorp reported Q3 2026 adjusted diluted EPS of $1.04, above the $0.93 consensus, while net interest margin expanded 8 basis points to 4.31% and net interest income rose 1% quarter over quarter to $93.8 million. Management forecast 2027 NIM of 4.3%–4.5% and expects the Citizens merger to add about $350 million in loans and $550 million in deposits in Q4; the pending Capital acquisition is expected to close around late Q1 or early Q2 2027. Credit metrics were mixed: nonperforming loans declined 11%, but classified loans increased 21% quarter over quarter, and management expects criticized and classified balances to rise as Citizens loans are onboarded.

Analysis

The key distinction is between better core earnings power and a still-conditional path to delivering it. PEBO’s near-term margin benefit depends on repricing acquired assets and deposits, while the 2027 outlook also assumes multiple Fed hikes; a flatter or falling rate path would challenge that guide even if integration proceeds. The balance-sheet restructuring improves portfolio yield, but the realized securities loss and temporarily constrained growth show that staying below the $10B threshold has a real opportunity cost. After crossing it, fee pressure is a known later headwind, not a current-quarter issue.

The less visible execution risk is the combination of two integrations before Capital’s cost saves are fully realized. Rising benefit costs and expected higher credit provisioning can absorb revenue synergies, so headline NIM expansion need not translate into comparable EPS growth. Citizens-related criticized/classified loan increases will partly reflect portfolio onboarding; distinguish that mechanical step-up from deterioration in legacy PEBO credits. Watch indirect consumer delinquencies and whether multifamily payoffs continue to outrun new commercial production.

Near term, the adjusted beat supports sentiment, but GAAP results and merger costs temper the signal. Over 1–3 months, Citizens close, asset repricing, deposit competition, and credit marks are the key checkpoints. Over 6–18 months, Capital integration and realized cost saves determine whether the growth franchise earns its promised operating leverage. Contrarian point: the market may over-credit stated NIM expansion and underweight expense/credit absorption; the acquired franchise’s growth is valuable only if it converts to risk-adjusted returns.

Key Decisions for Investors

• Avoid chasing PEBO solely on the adjusted EPS beat. Consider a small relative-value long PEBO / short KRE after the Citizens close only if reported core NIM lifts as guided and legacy criticized/classified balances stabilize; this limits broad regional-bank exposure while retaining execution upside.
• Use the next two quarters as confirmation points: track deposit costs and beta, core fee income excluding volatile lease gains, provision/allowance, and expense run rate. If margin uplift is offset by expense or provision growth, reduce or exit the relative-value position.
• Treat CBNK as a deal-monitoring position, not a standalone growth proxy: verify closing conditions, exchange terms, and any updated integration or credit disclosures before sizing. The thesis is falsified by a delayed/changed transaction or evidence that acquired growth requires materially higher credit costs.
• Risk alert: rising indirect-loan delinquencies, renewed multifamily payoff pressure, or a Fed path short of management’s assumed hikes would weaken PEBO’s earnings trajectory. The longer-dated Durbin fee reduction is a valuation headwind to incorporate over time, not a near-term catalyst.